See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days

News Digest / Income Statements

Income Statements

08:06am, Thursday, May 15, 2025

Invivyd Reports First Product Revenue as Losses Decline, Yet Faces Long-Term Financial Concerns

Company Overview: Invivyd, Inc. (NASDAQ: IVVD) is focused on developing monoclonal antibodies (mAbs) for serious viral infectious diseases, primarily COVID-19 through its product PEMGARDA™ (pemivibart). Key Financial Highlights: Revenue: Product revenue for Q1 2025 reached $11.3 million, marking...

08:05am, Thursday, May 15, 2025

Venus Concept Reports Declining Revenue and Increased Losses in Q1 2025 Financial Overview

08:05am, Thursday, May 15, 2025

Zenas BioPharma Reports First Revenue Amid High Losses and Regulatory Challenges in Q1 2025

Z

08:04am, Thursday, May 15, 2025

DT Cloud Acquisition Reports Strong Q1 Growth Amid Serious Financial Challenges and Business Deal Prospects

08:04am, Thursday, May 15, 2025

FitLife Brands Reports Q1 2025 Earnings: Revenue Declines While Core Segment Grows

08:04am, Thursday, May 15, 2025

Incannex Healthcare Reports Increased Losses and Steady Cash Position in Latest Financial Update

08:03am, Thursday, May 15, 2025

Precision BioSciences Advances Gene Therapy Trials Amidst Financial Challenges and Revenue Decline

08:02am, Thursday, May 15, 2025

Abeona Therapeutics Reports Q1 2025 Results: FDA Approves ZEVASKYN™ Amid Improved Financials

08:02am, Thursday, May 15, 2025

Pyxis Oncology Faces Financial Challenges Amid Promising Drug Developments in Oncology Market

08:02am, Thursday, May 15, 2025

Palvella Therapeutics Reports Q1 2025 Losses Amid Increased R&D and Operational Costs

08:01am, Thursday, May 15, 2025

Galectin Therapeutics Reports Improved Q1 Performance Amidst Cash Concerns and Ongoing Trials

08:01am, Thursday, May 15, 2025

Aclarion Reports Q1 2025: Revenue Up 88% Despite Rising Costs and Net Loss Improvement

08:00am, Thursday, May 15, 2025

TriSalus Life Sciences Reports Q1 2025 Growth Amid Financial Challenges and Increased Net Loss

07:04am, Thursday, May 15, 2025

Journey Medical Reports Mixed Q1 2025 Results Amid Revenue Growth and Rising Operational Costs

D

07:03am, Thursday, May 15, 2025

Nuvera Communications Reports 5.5% Revenue Growth Amid Challenges in Voice and Video Services

07:03am, Thursday, May 15, 2025

Black Spade Acquisition II Co Reports Modest Net Income Amid Rising Costs and Business Strategy Shift

07:02am, Thursday, May 15, 2025

Aura Biosciences Reports $27.5M Q1 Loss Amid Heavy R&D Spending and Reliance on Unproven Product

A

07:02am, Thursday, May 15, 2025

GBT Technologies Faces Financial Struggles with Major Losses and Growing Stockholders’ Deficit

07:02am, Thursday, May 15, 2025

Community Bancorp Reports Strong Q1 2025: 25% Net Income Rise Amid Asset Decline Concerns

C

07:01am, Thursday, May 15, 2025

Vystar Corporation Faces Financial Turmoil with 66% Revenue Drop and Rising Losses in Q1 2025

07:01am, Thursday, May 15, 2025

Cosmos Group Holdings Sees 100% Revenue Growth Amid Persistent Losses and High Debt Challenges

07:00am, Thursday, May 15, 2025

DSwiss Reports 112% Revenue Surge Amid Rising Costs and Declining Net Income in Q1 2025

D

07:00am, Thursday, May 15, 2025

Bubblr, Inc. Reports Q1 2025 Losses; New AI Products Key to Future Recovery

06:12pm, Wednesday, May 14, 2025

Red Cat Holdings Faces Major Losses Amid Liquidity Challenges and Strategic Acquisition Moves

06:11pm, Wednesday, May 14, 2025

Armlogi Holding Corp. Reports Strong Revenue Growth in Q1 FY2025 Despite Increased Losses

B

06:11pm, Wednesday, May 14, 2025

Talphera Reports Q1 2025: Revenue Growth and Reduced Losses Amid Ongoing Financial Challenges

06:10pm, Wednesday, May 14, 2025

Salarius Pharmaceuticals Faces Financial Struggles Amid Merger Deal and Delisting Threats

06:10pm, Wednesday, May 14, 2025

Lipella Pharmaceuticals Reports Q1 2025 Results: Increased Cash Reserves Amid Wider Net Loss

L

06:10pm, Wednesday, May 14, 2025

GlycoMimetics Reports Q1 2025 Losses, Plans Merger with Crescent Biopharma to Navigate Challenges

06:09pm, Wednesday, May 14, 2025

Blaize Holdings Faces Major Losses Despite Revenue Surge After BurTech Merger

06:09pm, Wednesday, May 14, 2025

Bunker Hill Mining Reports Mixed Q1 Results Amid Restructuring and Operational Challenges

06:09pm, Wednesday, May 14, 2025

Stardust Power Reports Q1 2025 Financials: Rising Cash but No Revenue and Escalating Losses

06:08pm, Wednesday, May 14, 2025

Two Hands Corporation Reports Zero Sales Amid Q1 2025 Financial Struggles and Cost Management Gains

T

06:07pm, Wednesday, May 14, 2025

Aldeyra Therapeutics Reports Q1 2025 Losses Amidst Strong Cash Position and Clinical Pipeline Potential

06:07pm, Wednesday, May 14, 2025

bluebird bio Reports Financial Challenges Despite Revenue Growth and Cost Reductions in Q1 2025

06:06pm, Wednesday, May 14, 2025

Natural Alternatives International Reports Q3 2025: Sales Rise Amid Increasing Losses

06:06pm, Wednesday, May 14, 2025

Horizon Kinetics Reports Mixed Q1 Results: Revenue Up 63% but Net Income Falls Sharply

06:05pm, Wednesday, May 14, 2025

Glucotrack Inc. Reports Increased Losses Amid Advances in Blood Glucose Monitoring Technology

G

06:05pm, Wednesday, May 14, 2025

Knightscope Reports 29% Revenue Growth Amid Ongoing Challenges and Decreasing Net Losses

06:05pm, Wednesday, May 14, 2025

Arbutus Biopharma Faces Challenges Amid Restructuring, Legal Battles, and Revenue Growth

«
1
2
...
64
65
66
67
68
69
70
...
111
112
»